Lombardi Cancer Center, Georgetown University — Washington D.C., District of Columbia

Lombardi Cancer Center, Georgetown University is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Lombardi Cancer Center, Georgetown University has participated in 14 clinical trials.

Therapeutic areas: Lung Cancer, Prostate Cancer, Ovarian Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, Gynecologic Oncology Group, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Cancer Center, Georgetown University?

Lombardi Cancer Center, Georgetown University has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Cancer Center, Georgetown University conducted?

Lombardi Cancer Center, Georgetown University has 14 clinical trials on record. Their work covers Lung Cancer, Prostate Cancer, Ovarian Cancer.

Is Lombardi Cancer Center, Georgetown University accredited by Crixeo Health?

Yes — Lombardi Cancer Center, Georgetown University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lombardi Cancer Center, Georgetown University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.